The Health Burden of Primary Biliary Cirrhosis (PBC) in Switzerland
Condition:   Primary Biliary Cirrhosis Intervention:   Sponsors:   Benedetta Terziroli, MD;   Fondazione Epatocentro Ticino;   Vifor Pharma;   Intercept Pharmaceuticals Recruiting - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 25, 2016 Category: Research Source Type: clinical trials

The Health Burden of Primary Biliary Cirrhosis (PBC) in Switzerland
Condition:   Primary Biliary CirrhosisIntervention:  Sponsors:   Benedetta Terziroli, MD;   Fondazione Epatocentro Ticino;   Vifor Pharma;   Intercept PharmaceuticalsRecruiting - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 25, 2016 Category: Research Source Type: clinical trials

The Health Burden of Primary Biliary Cirrhosis (PBC) in Switzerland
< b > Condition < /b > :   Primary Biliary Cirrhosis < br/ > < b > Intervention < /b > :   < br/ > < b > Sponsors < /b > :   Benedetta Terziroli, MD;   Fondazione Epatocentro Ticino;   Vifor Pharma;   Intercept Pharmaceuticals < br/ > < b > Recruiting < /b > - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 25, 2016 Category: Research Source Type: clinical trials

The Health Burden of Primary Biliary Cirrhosis (PBC) in Switzerland
Condition:   Primary Biliary Cirrhosis Intervention:   Sponsors:   Benedetta Terziroli, MD;   Fondazione Epatocentro Ticino;   Vifor Pharma;   Intercept Pharmaceuticals Recruiting - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 25, 2016 Category: Research Source Type: clinical trials

Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis
Condition:   Primary Biliary CirrhosisInterventions:   Drug: Fenofibrate;   Drug: UDCASponsor:   Xijing Hospital of Digestive DiseasesRecruiting - verified January 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 28, 2016 Category: Research Source Type: clinical trials